RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+19.74%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.6B
AUM Growth
+$1.6B
(+18%)
Cap. Flow
+$96.8M
Cap. Flow
% of AUM
6.07%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
150
New
14
Increased
55
Reduced
11
Closed
12
Top Buys
| 1 |
Merck
MRK
|
$36.7M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$15.8M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$14.7M |
| 4 |
Danaher
DHR
|
$12.5M |
| 5 |
PTHN
Patheon N.V.
PTHN
|
$11.9M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$19.8M |
| 2 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$18M |
| 3 |
Thermo Fisher Scientific
TMO
|
$14.8M |
| 4 |
Pediatrix Medical
MD
|
$9.61M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$8.41M |
Sector Composition
| 1 | Healthcare | 81.88% |
| 2 | Financials | 3.67% |
| 3 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.98B
| $10.6M | 0.67% |
173,000
+42,000
| +32% | +$2.58M |
|
52
Ultragenyx Pharmaceutical
RARE
$3.04B
| $10.4M | 0.65% |
147,000
+5,500
| +4% | +$390K |
|
53
Hologic
HOLX
$14.7B
| $9.81M | 0.61% |
252,500
+22,500
| +10% | +$874K |
|
|
FPRX
54
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.73M | 0.55% |
166,250
+13,250
| +9% | +$695K |
|
|
BOLD
55
DELISTED
Audentes Therapeutics, Inc
BOLD
| $8.64M | 0.54% |
+485,000
| New | +$8.64M |
|
56
Alkermes
ALKS
$4.95B
| $8.61M | 0.54% |
183,027
-11,473
| -6% | -$540K |
|
57
Exact Sciences
EXAS
$9.33B
| $8.08M | 0.51% |
+435,000
| New | +$8.08M |
|
58
Vertex Pharmaceuticals
VRTX
$102B
| $7.83M | 0.49% |
89,750
+4,250
| +5% | +$371K |
|
|
NVTA
59
DELISTED
Invitae Corporation
NVTA
| $7.8M | 0.49% |
890,000
+31,620
| +4% | +$277K |
|
60
Willis Towers Watson
WTW
$31.9B
| $7.77M | 0.49% |
+58,500
| New | +$7.77M |
|
|
HRC
61
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $7.44M | 0.47% |
120,000
| – | – |
|
62
Corvus Pharmaceuticals
CRVS
$419M
| $7.4M | 0.46% |
450,000
| – | – |
|
63
Insmed
INSM
$30.3B
| $7.3M | 0.46% |
503,000
+5,500
| +1% | +$79.9K |
|
|
KA
64
DELISTED
Kineta, Inc. Common Stock
KA
| $7.02M | 0.44% |
450,000
+35,000
| +8% | +$546K |
|
|
ONC
65
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $6.93M | 0.43% |
225,000
| – | – |
|
66
Regeneron Pharmaceuticals
REGN
$59.8B
| $6.83M | 0.43% |
17,000
| – | – |
|
|
ISEE
67
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.83M | 0.43% |
148,000
+5,500
| +4% | +$254K |
|
68
MacroGenics
MGNX
$121M
| $6.73M | 0.42% |
225,000
| – | – |
|
69
Rigel Pharmaceuticals
RIGL
$710M
| $6.64M | 0.42% |
1,810,000
+60,000
| +3% | +$220K |
|
70
Ligand Pharmaceuticals
LGND
$3.25B
| $6.63M | 0.42% |
+65,000
| New | +$6.63M |
|
|
PRTK
71
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $6.54M | 0.41% |
502,500
+84,000
| +20% | +$1.09M |
|
|
EVHC
72
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $6.48M | 0.41% |
291,000
| – | – |
|
|
NVDQ
73
DELISTED
Novadaq Technologies Inc.
NVDQ
| $6.42M | 0.4% |
555,000
| – | – |
|
74
Merus
MRUS
$5.04B
| $6.42M | 0.4% |
383,000
+22,189
| +6% | +$372K |
|
|
EPZM
75
DELISTED
Epizyme, Inc
EPZM
| $6.32M | 0.4% |
642,500
+45,000
| +8% | +$443K |
|